Danny Windham is listed as an executive officer and director on 9 SEC Form D filings by 3 issuers between Dec 2011 and May 2025: Tango Tango, Inc. (Huntsville, AL — telecommunications — 2025; $5.87M reported sold to 33 investors), BioHSV Holdings, Inc. (Huntsville, AL — biotechnology — 2019–2022; $3M reported sold to 29 investors) and Kailos Genetics, Inc. (Huntsville, AL — biotechnology — 2011–2018; $1.98M reported sold to 8 investors).
What this means A repeat sponsor — 3 separate companies raised money with this person listed as executive officer and director, over about 14 years. Across those companies the filings report $10.8M sold in total.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 9 public filings for Danny Windham and found 4 differences: Form D filed 48 days after the first sale; Danny Windham's role changed at BioHSV Holdings, Inc.: director → executive officer, director; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.